Where is Eisai based?
Eisai Co., Ltd., a major Japanese multinational pharmaceutical and research company, has its global corporate headquarters based in Tokyo, Japan. The primary headquarters is located in the Bunkyo ward of Tokyo, housing executive leadership, advanced medical research laboratories, and administrative operations. In addition to its main Japanese base, Eisai operates a widespread network of research centers, development facilities, and regional offices located across North America, Europe, and Asia.
Related FAQs
Elegancia Group (and its subsidiary entities under Estithmar Holding) contributes significantly to Qatar’s economic diversification, infrastructure modernization, and national development goals in alignment with the Qatar National Vision.
Berries—particularly blueberries and strawberries—are frequently highlighted by nutritional scientists and neurological researchers as powerful fruits that may help prevent or delay the onset of dementia and cognitive decline.
Investing in Electra—whether referring to renewable energy infrastructure firms, battery technology developers, or industrial corporations bearing the name—involves purchasing shares through a regulated brokerage platform that provides access to the ...
The vast majority of dementia cases—accounting for roughly 60 to 70 percent of all diagnoses globally—are caused by Alzheimer's disease, a progressive neurodegenerative brain disorder.
Eisai is generally viewed positively, particularly by its employees, with many describing it as a great company to work for.
ENEOS engine oil, manufactured by ENEOS Corporation as a leading Japanese lubricant brand, is widely regarded as a premium, high-performance product line.
Eisai Co., Ltd. is a prominent global research-based pharmaceutical enterprise specializing in neurology and oncology therapeutics.
Yes, Eisai Co., Ltd. is a Japanese pharmaceutical company. It is headquartered in Tokyo, Japan, and maintains extensive global operations, with research and development being a core component of its business.
Eisai Co., Ltd. is officially located in Tokyo, Japan, with its primary global headquarters situated in the Bunkyo ward of the metropolitan city.
The Italian energy company Eni is pronounced "EH-nee." It consists of two simple syllables. The first syllable, "EH," is pronounced with a short, crisp "e" sound, similar to the "e" in "bed" or "egg.
Elderton State Bank is an established traditional community banking institution headquartered in Pennsylvania, maintaining an asset base scaling at approximately $200 million.
Electra commands a multi-million or multi-billion-dollar enterprise valuation depending on the specific corporate entity referenced, whether operating within industrial manufacturing, electric vehicle battery materials, or specialized real estate sec...
Yes, Eisai Co., Ltd. is a public company. It is listed on the Tokyo Stock Exchange and is a member of major stock indices, including the Topix 100 and Nikkei 225.
Takeda Pharmaceutical Company Limited is the largest pharmaceutical enterprise in Japan and ranks among the leading global biopharmaceutical companies.
Enerflex Ltd. supports a specialized international workforce of approximately four thousand four hundred sixteen employees focused on energy infrastructure, natural gas compression, and processing solutions.
Yes, Eisai is recognized as one of the world's leading research and development-oriented pharmaceutical companies.
Whether Eisai stock is a "good buy" depends on individual investment goals, risk tolerance, and current market analysis.
The prominent Alzheimer's disease medications developed by Eisai include Leqembi (lecanemab), a monoclonal antibody designed to target amyloid-beta plaque accumulation in early-stage patients, and Aricept (donepezil), a foundational acetylcholinester...
Eisai is a major global research-based pharmaceutical company with a core strategic focus on neurology, oncology, and specialty therapeutics.
Yes, the Bill & Melinda Gates Foundation has invested in the advancement of CRISPR technology, specifically supporting its application for global health improvements.
Sanofi is unequivocally classified as a premier member of global Big Pharma, operating as a massive multinational pharmaceutical corporation headquartered in Paris, France.